Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001853373-21-000001
Filing Date
2021-03-25
Accepted
2021-03-25 13:25:00
Documents
1
Effectiveness Date
2021-03-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4811
  Complete submission text file 0001853373-21-000001.txt   5815
Mailing Address 102 SEARS ROAD WAYLAND MA 01778
Business Address 102 SEARS ROAD WAYLAND MA 01778 617-460-3772
Kestrel Therapeutics Inc. (Filer) CIK: 0001853373 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-393522 | Film No.: 21771607